Watch Ticker

BeyondSpring Inc. Ordinary Shares

Go to BeyondSpring Inc. Ordinary Shares Website

$2.04

-0.12 (-5.32%)

Live

Previous Close

$2.16

Day Range

$2.03 - $2.16

Previous Day Range

$2.05 - $2.25

Market Cap

$83.5 million USD

Day Vol.

8720

Previous Day Vol.

20002

Currency

USD

Primary Exchange

Nasdaq

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment....

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

SEED Therapeutics received FDA designations for its lead oncology asset ST-01156, a molecular glue that degrades RBM39. The company also announced strategic transactions with its largest shareholder, BeyondSpring, to diversify its shareholder base.

Related tickers: BYSI.

Read Full Article

Beyondspring Inc. - BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

BeyondSpring announced the sale of a portion of its equity interest in SEED Therapeutics for $35.4 million. The proceeds will be used to advance the late-stage clinical trials of BeyondSpring's lead asset, Plinabulin, a first-in-class anti-cancer agent.

Related tickers: BYSI.

Read Full Article

Trending Tickers

Please sign in to view